循环核酸化酶5型活性在运动期间限制了血液流向过心肌的血流
1Department of Medicine, Division of Cardiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
作为PDE5抑制剂的西尔德纳菲尔,通过扩大冠状动脉血管,在运动期间增加了对缺血性心脏的血液流动. 这一发现对于了解其对冠状动脉狭窄和心肌 perfusion 的影响至关重要.
科学领域:
- 心血管生理学心血管生理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 氧化 (NO) 通过cGMP调节血管扩张,由固酶 (PDEs) 调节.
- 作为PDE5抑制剂的西尔德纳菲尔可以放松冠状动脉.
- 这项研究调查了西尔德纳菲尔在正常心脏和缺血心脏中炼期间对冠状动脉血流的影响.
研究的目的:
- 为了评估西尔代纳菲尔对冠状动脉血流和血液动力学的影响.
- 为了评估在运动期间正常和缺血条件下西尔代纳菲尔的疗效.
主要方法:
- 使用慢性仪器犬. 使用慢性仪器犬.
- 用于西尔代纳菲尔 (2毫克/公斤PO).
- 在休息和跑步机运动期间测量冠状动脉血流和血液动力学,有和没有诱导的冠状动脉狭窄.
主要成果:
- 在正常的狗中,西尔德纳菲尔略微增加了静止冠状动脉血流.
- 在狭窄的情况下炼显著降低了冠状动脉血流.
- 在炼期间,西尔德纳菲尔增加了缺血区域的血液流动.
结论:
- 用西尔代纳菲尔抑制PDE5扩大冠状动脉抵抗血管.
- 在有狭窄的情况下,在运动期间,西尔德纳菲尔增强了对缺血性心肌的血液流动.
更多相关视频
09:04Skeletal Muscle Neurovascular Coupling, Oxidative Capacity, and Microvascular Function with 'One Stop Shop' Near-infrared Spectroscopy
Published on: February 20, 2018
08:46Real-time Evaluation of Absolute, Cytosolic, Free Ca2+ and Corresponding Contractility in Isolated, Pressurized Lymph Vessels
Published on: March 22, 2024
相关概念视频
Pathophysiology of Cardiac Performance
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Nitric Oxide Signaling Pathway
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Physiology of the Heart: The Cardiac Cycle
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
Antihypertensive Drugs: Action of Calcium Channel Blockers
